CN106511471A - Fig oral cavity spray and preparation method thereof - Google Patents
Fig oral cavity spray and preparation method thereof Download PDFInfo
- Publication number
- CN106511471A CN106511471A CN201611077374.9A CN201611077374A CN106511471A CN 106511471 A CN106511471 A CN 106511471A CN 201611077374 A CN201611077374 A CN 201611077374A CN 106511471 A CN106511471 A CN 106511471A
- Authority
- CN
- China
- Prior art keywords
- fructus fici
- fruit
- extract
- powder
- oral spray
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 42
- 239000007921 spray Substances 0.000 title abstract description 27
- 210000000214 mouth Anatomy 0.000 title abstract description 26
- 239000000284 extract Substances 0.000 claims abstract description 99
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 73
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 65
- 239000000843 powder Substances 0.000 claims abstract description 62
- 229930182490 saponin Natural products 0.000 claims abstract description 41
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims abstract description 40
- 150000007949 saponins Chemical class 0.000 claims abstract description 40
- 239000008367 deionised water Substances 0.000 claims abstract description 22
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 22
- 229940099352 cholate Drugs 0.000 claims abstract description 18
- 239000003755 preservative agent Substances 0.000 claims abstract description 13
- 230000002335 preservative effect Effects 0.000 claims abstract description 13
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 claims abstract 5
- 229940041678 oral spray Drugs 0.000 claims description 54
- 239000000668 oral spray Substances 0.000 claims description 54
- 241001062954 Clinopodium Species 0.000 claims description 43
- 244000025254 Cannabis sativa Species 0.000 claims description 42
- 238000004108 freeze drying Methods 0.000 claims description 32
- 238000010521 absorption reaction Methods 0.000 claims description 30
- 239000011259 mixed solution Substances 0.000 claims description 29
- 239000000203 mixture Substances 0.000 claims description 27
- 239000003623 enhancer Substances 0.000 claims description 26
- 239000008176 lyophilized powder Substances 0.000 claims description 26
- 244000025361 Ficus carica Species 0.000 claims description 17
- 235000008730 Ficus carica Nutrition 0.000 claims description 17
- 238000000605 extraction Methods 0.000 claims description 17
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 17
- 238000001035 drying Methods 0.000 claims description 14
- 239000000706 filtrate Substances 0.000 claims description 13
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 10
- 229910052708 sodium Inorganic materials 0.000 claims description 10
- 239000011734 sodium Substances 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 9
- 239000000243 solution Substances 0.000 claims description 9
- 230000000844 anti-bacterial effect Effects 0.000 claims description 8
- 229910052796 boron Inorganic materials 0.000 claims description 8
- UBLAMKHIFZBBSS-UHFFFAOYSA-N 3-Methylbutyl pentanoate Chemical compound CCCCC(=O)OCCC(C)C UBLAMKHIFZBBSS-UHFFFAOYSA-N 0.000 claims description 7
- 241000206575 Chondrus crispus Species 0.000 claims description 7
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 108010015031 Glycochenodeoxycholic Acid Proteins 0.000 claims description 2
- GHCZAUBVMUEKKP-GYPHWSFCSA-N glycochenodeoxycholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCC(O)=O)C)[C@@]2(C)CC1 GHCZAUBVMUEKKP-GYPHWSFCSA-N 0.000 claims description 2
- JAJWGJBVLPIOOH-IZYKLYLVSA-M sodium taurocholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 JAJWGJBVLPIOOH-IZYKLYLVSA-M 0.000 claims description 2
- 235000010358 acesulfame potassium Nutrition 0.000 claims 1
- KDFQYGBJUYYWDJ-UHFFFAOYSA-N azane;sodium Chemical compound N.[Na] KDFQYGBJUYYWDJ-UHFFFAOYSA-N 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 31
- 230000036541 health Effects 0.000 abstract description 9
- 206010061218 Inflammation Diseases 0.000 abstract description 6
- 230000001737 promoting effect Effects 0.000 abstract description 5
- 241000894006 Bacteria Species 0.000 abstract description 4
- 230000004054 inflammatory process Effects 0.000 abstract description 2
- 229940124532 absorption promoter Drugs 0.000 abstract 2
- 230000000740 bleeding effect Effects 0.000 abstract 1
- 230000003467 diminishing effect Effects 0.000 abstract 1
- 238000009499 grossing Methods 0.000 abstract 1
- 238000009776 industrial production Methods 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 235000019645 odor Nutrition 0.000 abstract 1
- 235000017709 saponins Nutrition 0.000 description 36
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 17
- 210000003800 pharynx Anatomy 0.000 description 13
- 239000000047 product Substances 0.000 description 13
- 229910000831 Steel Inorganic materials 0.000 description 12
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 12
- BHQCQFFYRZLCQQ-OELDTZBJSA-M cholate Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-M 0.000 description 12
- 229930003944 flavone Natural products 0.000 description 12
- 235000011949 flavones Nutrition 0.000 description 12
- ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical compound C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 description 12
- 239000010959 steel Substances 0.000 description 12
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 12
- 150000002212 flavone derivatives Chemical class 0.000 description 10
- 150000004676 glycans Chemical class 0.000 description 10
- 229920001282 polysaccharide Polymers 0.000 description 10
- 239000005017 polysaccharide Substances 0.000 description 10
- 206010013786 Dry skin Diseases 0.000 description 8
- 235000008504 concentrate Nutrition 0.000 description 8
- 239000012141 concentrate Substances 0.000 description 8
- 238000005292 vacuum distillation Methods 0.000 description 8
- 241000700199 Cavia porcellus Species 0.000 description 7
- VXGRJERITKFWPL-UHFFFAOYSA-N 4',5'-Dihydropsoralen Natural products C1=C2OC(=O)C=CC2=CC2=C1OCC2 VXGRJERITKFWPL-UHFFFAOYSA-N 0.000 description 6
- -1 Flavone compound Chemical class 0.000 description 6
- 201000007100 Pharyngitis Diseases 0.000 description 6
- 239000000443 aerosol Substances 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 229940095708 oral spray product Drugs 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- 230000008859 change Effects 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 229960004756 ethanol Drugs 0.000 description 5
- 239000000835 fiber Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 241000390128 Eutrema Species 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 244000195452 Wasabia japonica Species 0.000 description 4
- 235000000760 Wasabia japonica Nutrition 0.000 description 4
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- 235000013619 trace mineral Nutrition 0.000 description 4
- 239000011573 trace mineral Substances 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 241000218218 Ficus <angiosperm> Species 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000002421 anti-septic effect Effects 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000013329 compounding Methods 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000007938 effervescent tablet Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 230000001408 fungistatic effect Effects 0.000 description 3
- 150000002596 lactones Chemical class 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 239000000693 micelle Substances 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 102000013142 Amylases Human genes 0.000 description 2
- 108010065511 Amylases Proteins 0.000 description 2
- 240000003291 Armoracia rusticana Species 0.000 description 2
- 235000011330 Armoracia rusticana Nutrition 0.000 description 2
- 241001672694 Citrus reticulata Species 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 241000207923 Lamiaceae Species 0.000 description 2
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 239000006189 buccal tablet Substances 0.000 description 2
- 229940046011 buccal tablet Drugs 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 229940125532 enzyme inhibitor Drugs 0.000 description 2
- 239000002532 enzyme inhibitor Substances 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 210000000867 larynx Anatomy 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 240000001624 Espostoa lanata Species 0.000 description 1
- 235000009161 Espostoa lanata Nutrition 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010007979 Glycocholic Acid Proteins 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 235000017286 Melicoccus bijugatus Nutrition 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- RFDAIACWWDREDC-UHFFFAOYSA-N Na salt-Glycocholic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(=O)NCC(O)=O)C)C1(C)C(O)C2 RFDAIACWWDREDC-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 241000255964 Pieridae Species 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 101710196222 Protein 4.3 Proteins 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 240000002017 Solanum caripense Species 0.000 description 1
- 235000018675 Solanum caripense Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 241001627955 Tetraodon lineatus Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 235000009392 Vitis Nutrition 0.000 description 1
- 241000219095 Vitis Species 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000002225 anti-radical effect Effects 0.000 description 1
- 230000003005 anti-senility effect Effects 0.000 description 1
- 230000003260 anti-sepsis Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 239000010242 baoji Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000001354 calcination Methods 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000035613 defoliation Effects 0.000 description 1
- 229960000935 dehydrated alcohol Drugs 0.000 description 1
- 238000002242 deionisation method Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 229940111205 diastase Drugs 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 235000011869 dried fruits Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000021022 fresh fruits Nutrition 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 235000019990 fruit wine Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- RFDAIACWWDREDC-FRVQLJSFSA-N glycocholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 RFDAIACWWDREDC-FRVQLJSFSA-N 0.000 description 1
- 229940099347 glycocholic acid Drugs 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000011554 guinea pig model Methods 0.000 description 1
- 210000004247 hand Anatomy 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 238000011645 inflammation animal model Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229940127249 oral antibiotic Drugs 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N p-menthan-3-ol Chemical compound CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 229940093429 polyethylene glycol 6000 Drugs 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 235000013324 preserved food Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000021264 seasoned food Nutrition 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 235000020374 simple syrup Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- WDFRNBJHDMUMBL-OICFXQLMSA-M sodium;(4r)-4-[(3r,5s,7r,8r,9s,10s,13r,14s,17r)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]pentanoate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)CC1 WDFRNBJHDMUMBL-OICFXQLMSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- DKVBOUDTNWVDEP-NJCHZNEYSA-N teicoplanin aglycone Chemical compound N([C@H](C(N[C@@H](C1=CC(O)=CC(O)=C1C=1C(O)=CC=C2C=1)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)OC=1C=C3C=C(C=1O)OC1=CC=C(C=C1Cl)C[C@H](C(=O)N1)NC([C@H](N)C=4C=C(O5)C(O)=CC=4)=O)C(=O)[C@@H]2NC(=O)[C@@H]3NC(=O)[C@@H]1C1=CC5=CC(O)=C1 DKVBOUDTNWVDEP-NJCHZNEYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/37—Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Dispersion Chemistry (AREA)
- Botany (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention discloses fig oral cavity spray and a preparation method thereof. The fig oral cavity spray is composed of, on the basis of 1000ml, 50 g to 150 g of fig fruit extract freeze-dried powder, 2 g to 6 g of preservative, 40 g to 80 g of absorption promoter and the balance deionized water. The absorption promoter is prepared from Herba Clinopodii Chinensis saponin and cholate. The fig oral cavity spray has the effects of inhibiting bacteria, diminishing inflammation, stopping bleeding, smoothing the throat, removing odors and the like, is convenient to use and meets the needs of modern people for oral hygiene and health. The preparation method of the fig oral cavity spray is easy to operate and control and suitable for industrial production and has high promotional value.
Description
Technical field
The present invention relates to food and field of health care products, and in particular to a kind of Fructus Fici oral spray and preparation method thereof.
Background technology
Fructus Fici (Ficus caricaLinn.) also known as mamoncillo, syconium, bright mouth fruit, Fructus Fici Beecheyanae, Fructus Fici Heteromo, Gu Duzi,
Category Moraceae Ficus deciduous tree or shrub, are mainly grown on the torrid zone and temperate zone, belong to subtropical zones defoliation small arbor, and trunk is high, tree crown
Greatly, blade face width, two season of autumn in summer result.Fig fruit thin skin is seedless, and meat is soft, and local flavor is sweet, containing various saccharides material,
Flavone compound, organic acid, protein, trace element and vitamin C (Vc) isoreactivity composition, nutrition very abundant, have
Very high nutritive value and medical value.Containing the material with bacteriostatic activity in common fig leaf juice:Psoralen, benzaldehyde and Buddhist
The materials such as handss Citrus chachiensis Hort. lactone, it is with goodish Development volue and application prospect, but in real life production, most
Common fig leaf juice is all abandoned as waste, causes the significant wastage of resource, if developing its new purposes, can improve nature money
The value in source.
Determine according to Agricultural University Of Nanjing, in fig fruit, contain protein 4.3%, carbohydrate 74.3% is (wherein really
Sugar and glucose account for 15%-20%), and rich in trace element such as Ca, Mg, Zn, Na, Cu, B, containing 18 kinds of aminoacid, wherein have
10 kinds is aminoacid necessary to human body, 2 kinds of child's essential amino acids, aspartic acid content 0.475%-0.493%, Vc
Content be 2-3 times of mandarin orange, 20 times of Fructus Vitis viniferae, also containing it is substantial amounts of can adsorb various harmful substances in intestinal, purification intestinal,
Exclude the dietary fiber such as pectin of carcinogenic chemical, and the diastase of defying age, superoxide dismutase, esterase, ester
The materials such as fat enzyme, protease.The exploitation of Fructus Fici is concentrated mainly on fresh fruit storage and the shallower aspect such as edible, medicinal to its fruit
Value, the synthesis of fruit tree send out that research on utilization is less, therefore Fructus Fici is put into the category of anxious third generation fruit leaved for development, have compared with
Big researching value.
On market, existing Fructus Fici class product has health tea, fruit wine, oral liquid, fruit juice, buccal tablet, crispy slice, effervescent tablet, fruit
Piece, cookiess, health-caring capsule, extractum, fruit jam, dried fruitss, preserved fruit, canned food etc..Such as Chinese patent ZL201410203890.6 is disclosed
A kind of Fructus Fici effervescent tablet, is made up of the component of following weight portion:Fructus Fici crude polysaccharides 10-30 parts, vitamin C 5-
10 parts, filler 4-10 parts, acid compound 10-30 parts, alkali compoundss 10-50 parts, lubricant 0.5-5 parts, binding agent 1-4
Part;The filler is selected from any one in starch, Icing Sugar, Mannitol, dextrin, sucrose or arbitrarily several combinations;The acid
Property compound selected from citric acid, tartaric acid, fumaric acid, adipic acid, any one or arbitrarily several combinations in malic acid;It is described
Alkali compoundss are selected from sodium bicarbonate or/and sodium carbonate;The lubricant is selected from polyethylene glycol 6000 or/and micropowder silica gel;Institute
Binding agent is stated selected from dehydrated alcohol, polyvinylpyrrolidone, any one or arbitrarily several combinations in hydroxypropyl cellulose;Should
Fructus Fici effervescent tablet, fig polysaccharide purity are high, and content is big, is of high nutritive value, can give full play to its health-care effect.At present also
It is not directed to oral spray field.In view of Fructus Fici has significantly throat effect such as treatment laryngalgia, subduing swelling and detoxicating, can be by
Which develops into such functional health product.And existing oral spray is such as:Disclosed in Chinese patent ZL201010173269.1
A kind of oral spray, it mainly include water solublity Mentholum, fresh breath material, sweeting agent, xylitol, ethanol and go from
Sub- water, it is adaptable to refresh oneself when working, learning or fresh breath.Sweeting agent side effect in the formula is more and can cause fertilizer
The health problems such as fat, hypertension, hyperglycemia, and the spray curative effect is general, acts on single, and practicality is poor.Chinese patent
ZL201310209226.8 discloses a kind of horseradish oral spray, and the raw material of the oral spray has Wasabia japonic (Euterma Wasabi) extracting solution, solubilising
Agent, absorption enhancer, correctivess, simple syrup and ethanol solution surplus.Although the oral spray can help eliminate oral cavity and throat
Inflamed sites inflammation, suppresses antibacterial in the growth at pharyngolaryngitis erosion position, but Wasabia japonic (Euterma Wasabi) is the one kind found in the world today
Special edible health plant, is extremely precious seasoned food in the international market, and the expensive, market demand is very big.By
In Wasabia japonic (Euterma Wasabi) growth conditionss are special, it is limited where suitable growth plantation, Wasabia japonic (Euterma Wasabi) product is extremely rare, causes horseradish oral spray
It is expensive, it is impossible to popularity.Fructus Fici price is relatively low, and containing a large amount of in fig fruit and its leaf extract
Active component, including flavone, vitamin, trace element, amylase, lipase, protein, antifatigue anti senility asparagine
Acid, the antihypertensive Fructus Citri Sarcodactyliss lactone of anti-cancer and cancer-preventing, psoralen, benzaldehyde, polysaccharose substance etc., nutrition very abundant, tool
There are the action and efficacies such as nourishing the lung to arrest cough, invigorating the stomach and promoting bowel movement, subduing swelling and detoxicating, anti-inflammation detumescence, throat, and yield be high, cultivation management is easy,
Low price, economic worth are higher.Therefore, will have a wide range of applications if successfully developing Fructus Fici oral spray class product
Value.
The content of the invention
For existing market situation, prepared as raw material the invention provides a kind of with fig fruit extract freeze-drying powder
Fructus Fici oral spray.The Fructus Fici oral spray, with antibacterial, antiinflammatory, stop blooding, wet one's whistle, the multiple efficacies such as deodorize, make
With convenient, Modern human populations oral hygiene health demand is adapted to.
Present invention also offers a kind of preparation method of Fructus Fici oral spray, the method is simple to operate, it is easy to control,
Industrialized production is suitable to, with preferable promotional value.
A kind of Fructus Fici oral spray, it is in terms of 1000mL, composed of the following components:
Fig fruit extract freeze-drying powder 50g-150g;
Preservative 2g-6g;
Absorption enhancer 40g-80g;
Balance of deionized water.
In above-mentioned formula, the preservative selects fig leaf extract, and its main component is psoralen, can conduct
A kind of new natural antisepsis fresh-keeping agent, with good antibacterial antiseptic effect.
The absorption enhancer is made up of clinopodium grass saponin and cholate, wherein, the quality of clinopodium grass saponin and cholate
Than being preferably 3:1.Clinopodium grass saponin and cholate have preferable potentiation between the two, and clinopodium grass saponin is natural as one kind
Nonionic surfactant, small colloidal particle can be formed in water, by formed micelle effect Fructus Fici is carried
In taking thing, flavone, polysaccharide and psoralen isoreactivity composition are attached together, and increase the permeability of iuntercellular water solublity passage,
Promote the absorption of water-soluble substanceses;And the cholate of low concentration with aquation and can extract intercellular lipid, carry so as to increased
Diffusion of the thing in iuntercellular aqueous channels is taken, while cholate, can change many by affecting the activity of enzyme as enzyme inhibitor
The different mechanism such as peptide, protein conformation maintains stablizing for medicine, can be bright with surfactant clinopodium grass saponin compounding by which
The absorption of aobvious increase Fructus Fici oral spray effective ingredient.Described cholate selects commercially available prod, can select glycocholic acid
In sodium, glycochenodeoxycholate sodium, sodium taurocholate, Irish moss (chondrux) sodium, NaTDC etc. one or two with
On.
In order to reach more preferable invention effect, it is preferable that described Fructus Fici oral spray, in terms of 1000mL, by following
Component is constituted:
Fig fruit extract freeze-drying powder 80g-150g;
Preservative 2g-5g;
Absorption enhancer 40g-72g;
Balance of deionized water.
Described fig fruit extract freeze-drying powder can be using existing fig fruit extract freeze-drying powder (as commercially available
Product) or using the fig fruit extract freeze-drying powder of prior art preparation, it is preferred to use following preparation method is prepared into
The fig fruit extract freeze-drying powder for arriving:
The preparation method of described fig fruit extract freeze-drying powder, comprises the following steps:
Fig fruit obtains fig fruit powder (preferably crossing 60 mesh sieves) Jing after clean, lyophilizing and crushing;Will be without flower
Fruits powder carries out Subcritical water chromotagraphy by extracting solution of subcritical water, and extraction time is 10min-40min;Subcritical hydraulic pressure
Power is 4MPa-7MPa, and temperature is 120 DEG C -180 DEG C, and flow velocity is 5L/h-10L/h;The concentrated drying of extract for obtaining is (preferably
In 55 DEG C of vacuum distillation concentrate dryings), lyophilizing, obtain containing the multicomponents such as fig polysaccharide, flavone and cellulose activity nothing
Flowers and fruits fruit extract lyophilized powder.
Described fig leaf extract can adopt existing fig leaf extract (such as commercially available prod) or using existing
The fig leaf extract for having technology to prepare, described fig leaf extract preferably select dried fig leaf extract
Such as fig leaf extract lyophilized powder, is easy to prepare spray, is further preferably prepared using following preparation method
Fig leaf extract:
The preparation method of described fig leaf extract, comprises the following steps:
Common fig leaf juice obtains common fig leaf juice powder Jing after clean, lyophilizing and crushing;By common fig leaf juice powder with subcritical water
Subcritical water chromotagraphy is carried out for extracting solution, extraction time is 20min;Subcritical water pressure is 5MPa, and temperature is 130 DEG C, flow velocity
For 8L/h;By the extract for obtaining concentrated drying (preferably in 55 DEG C of vacuum distillation concentrate dryings) lyophilizing afterwards, Fructus Psoraleae is obtained
The higher fig leaf extract of cellulose content.
Described clinopodium grass saponin can adopt existing clinopodium grass saponin (such as commercially available prod) or adopt prior art system
Standby clinopodium grass saponin, described clinopodium grass saponin preferably select such as clinopodium grass saponin lyophilizing of dried clinopodium grass saponin
Powder, is easy to prepare spray, it is preferred to use the clinopodium grass saponin that following preparation method is prepared:
The preparation method of described clinopodium grass saponin, comprises the following steps:
Clinopodium grass is put into into supersound extraction 30min in the ethanol water of mass percentage concentration 80%, is filtrated to get once
Filtrate, filtering residue supersound extraction 30min in the ethanol water of mass percentage concentration 80% are filtrated to get secondary filtrate, merge
First-time filtrate and secondary filtrate obtain filtrate, and concentrating filter liquor (preferably in 30 DEG C of concentrating under reduced pressure), lyophilizing obtain higher degree
Clinopodium grass saponin extract.
The preparation method of described Fructus Fici oral spray, comprises the following steps:
(1) clinopodium grass saponin is mixed homogeneously into the accelerator that is absorbed with cholate;
(2) by absorption enhancer, preservative and appropriate amount of deionized water mix homogeneously, mixed solution A is obtained;
(3) in mixed solution A fig fruit extract freeze-drying powder, mix homogeneously is added to obtain mixed solution B;
(4) add deionized water in mixed solution B and be settled to 1000mL, obtain Fructus Fici mouthspray Jing after filtering antibacterial
Agent.
When preparing Fructus Fici oral spray, active component fig fruit extract freeze-drying powder is added and is prepared in advance
Containing absorption enhancer, the mixed solution A of preservative in, relative to traditional mixed once method, can preferably play this
Effect of invention absorption enhancer.
Obtained Fructus Fici oral spray is filled in aerosol apparatus, that is, Fructus Fici oral spray product is obtained.
In sum, Fructus Fici oral spray of the present invention is a kind of with various natural activity components, fungistatic effect
Significantly, with nourishing the lung to arrest cough, clearing away heat and moistening the bowels, the oral spray of removing toxic substances and promoting subsidence of swelling;The preparation of above recipe ingredient can be according to reality
Needs are adjusted.
Subcritical state is a kind of form relative to critical state and supercriticality.The pressure of control appropriateness, by water
100 DEG C are heated to the high temperature below 374 DEG C of upper critical temperature, water body stills remain in liquid condition, and its polarity can be with temperature
Degree changes and changes, and this water is referred to as subcritical water.Subcritical water has bigger difference in nature with the water under normal temperature and pressure, can
To adjust the polarity of subcritical water by controlling temperature and pressure, so as to reach the purpose of selective extraction target component, adopt
This new extractive technique of subcritical water extraction, can largely extract target component within a short period of time, and the technique has
Effective percentage height, cycle is short, advantages of environment protection, are with a wide range of applications in terms of active components of plants is extracted.
Clinopodium grass, another name:Herba Clinopodii Polycephali, Herba leucadis zeylanicae, Herba Clinopodii Polycephali, landing Flos Mume, nine towers are careless, red nine towers flower, wild Herba mesonae chinensiss, are
The herb of Labiatae (Labiatae) plant clinopodium grass ClinopodiumchinensisO.Kze..
The fresh fig fruit of fig fruit of the present invention and the preferred high-quality of common fig leaf juice and high-quality common fig leaf juice.
Beneficial effect of the present invention is:
1st, Ficus medicine-food two-purpose resource, has no toxic side effect, and by the use of common fig leaf juice extract as preservative,
Good antiseptic effect can be played, recycling for common fig leaf juice garbage can be realized again, the utilization of common fig leaf juice is improve
Rate.
2nd, compared with existing oral spray, antibiotic and ethanol is not contained in oral spray of the present invention, will not be caused
The generation of the bacterial drug resistance that antibiotic is caused, and be equally applicable for ethanol or alcohol sensible crowd.With existing product
Condition is more less than the adjuvant added in the present invention, can largely retain the unique fragrant of Fructus Fici.
3rd, in inventive formulation, main component is fig fruit extract, and its extract effective ingredient includes flavone, many
Sugar, aminoacid and trace element etc., the effects such as with excellent defying age, anticancer, anti-inflammation detumescence, throat.Common fig leaf juice
Extract high enrichment flavone compound and Coumarinses lactone nutrient, with good antiradical activities, have
Significantly antibacterial, antiinflammatory and antivirus action, as natural antibiotic antiseptic, can extend the storage of Fructus Fici mouthspray
Time.
4th, in inventive formulation, clinopodium grass belongs to Clinopodium, and the chemical composition of Clinopodium plant is extremely complex, containing Huang
The compounds such as ketone, saponinss, organic acid, the fragrant same clan, triterpeness, steroid, wherein saponins compound are planted for the category
The main active of thing, clinopodium grass saponin contain lipophilic triterpeness aglycon and the sugar chain compared with strongly hydrophilic, can be with nothing
Flowers and fruits extract combines to form micelle so as to which dissolubility in a solvent increases, with good solubilized absorbefacient effect.Wind
The careless saponin of wheel can form small colloidal particle, by shape in water as a kind of natural nonionic surfactant
Flavone, polysaccharide and psoralen isoreactivity composition in Fructus Fici extract are attached together into micelle effect, increase cell
Between water solublity passage permeability, promote water-soluble substanceses absorption;And the cholate of low concentration with aquation and can be extracted thin
Intercellular lipid, so as to increased diffusion of the extract in iuntercellular aqueous channels, while cholate can lead to as enzyme inhibitor
Crossing affects the activity of enzyme, changes the different mechanism such as polypeptide, protein conformation and maintains stablizing for medicine, by itself and surfactant
Clinopodium grass saponin compounding can significantly increase the absorption of Fructus Fici oral spray effective ingredient.
5th, all components in inventive formulation are the high composition of nontoxic, non-stimulated, security performance, and most of composition is
Extracted form natural plant active component, can be with safe to use.
6th, with regard to health fig product, current on the market mainly with moistening and cleaning throat as health care tablet, buccal tablet, granule,
Based on the dosage forms such as teabag, cream, mouthspray dosage form has easy to carry, takes the advantage of simple and fast, while the product was both
Protection throat can be played, the effect of fresh breath, the effects such as have health and beauty, prophylactic treatment oral cavity FAQs again.It is special
Laryngopharynx swelling and pain and prevention upper respiratory tract infection Shi Yongyu not be treated.
Specific embodiment
With reference to embodiments the present invention is described in further detail.
Embodiment 1
The preparation method of Fructus Fici oral spray, comprises the following steps:
1. the preparation of fig fruit extract freeze-drying powder:
(1.1) high-quality fresh fig fruit is selected, after rinsing well, lyophilizing in freeze dryer is put into;
(1.2) fig fruit after lyophilizing is shredded, is put into pulverizer and is ground into powder, cross 60 mesh sieves;
(1.3) dry fig fruit powder 120g is weighed, rustless steel is put into and is extracted in kettle, with subcritical water as extracting
Liquid carries out Subcritical water chromotagraphy to the powder, and extraction time is 10min;Rustless steel extract kettle in subcritical water pressure be
4MPa, temperature are 120 DEG C, and flow velocity is 5L/h;Obtain extract;
(1.4) said extracted thing is obtained containing fig polysaccharide, flavone and fiber in 55 DEG C of vacuum distillation concentrate dryings
The multicomponent activity extract of element etc., and lyophilizing is obtained fig fruit extract freeze-drying powder in placing it in freeze dryer.
2. the preparation of Fructus Fici spray:
A. 45g clinopodium grass saponin (purchased from bright biological development corporation, Ltd. of Baoji side) and 15g Irish moss (chondrux)s are taken
Sodium (purchased from Shanghai Yuan Ye bio tech ltd), mix homogeneously are absorbed accelerator 60g.
B. fig leaf extract lyophilized powder (purchased from Xi'an Bioisystech Co., Ltd of Tianrui) 6g and appropriate deionization are taken
Water is mixed and stirred in 250mL beakers uniformly, then which is uniformly mixed to prepare mixed solution A with 60g absorption enhancers.
C. 70g fig fruit extract freeze-drying powder mix homogeneously is added in mixed solution A, obtain mixed solution B.
D. add deionized water in mixed solution B and be settled to 1000mL, Fructus Fici mouth is obtained Jing after biofilter is filtered
Chamber spray, obtained spray is filled in aerosol apparatus, that is, Fructus Fici oral spray product is obtained.
Embodiment 2
The preparation method of Fructus Fici oral spray, comprises the following steps:
1. the preparation of fig fruit extract freeze-drying powder:
(1.1) high-quality fresh fig fruit is selected, after rinsing well, lyophilizing in freeze dryer is put into;
(1.2) fig fruit after lyophilizing is shredded, is put into pulverizer and is ground into powder, cross 60 mesh sieves;
(1.3) dry fig fruit powder 140g is weighed, rustless steel is put into and is extracted in kettle, with subcritical water as extracting
Liquid carries out Subcritical water chromotagraphy to the powder, and extraction time is 20min;Rustless steel extract kettle in subcritical water pressure be
5MPa, temperature are 130 DEG C, and flow velocity is 7L/h;Obtain extract;
(1.4) said extracted thing is obtained containing fig polysaccharide, flavone and fiber in 55 DEG C of vacuum distillation concentrate dryings
The multicomponent activity extract of element etc., and lyophilizing is obtained fig fruit extract freeze-drying powder in placing it in freeze dryer.
2. the preparation of fig leaf extract:
(2.1) common fig leaf juice of high-quality is selected, after rinsing well, lyophilizing in freeze dryer is put into;
(2.2) common fig leaf juice after lyophilizing is put into into pulverizer and is ground into powder, cross 60 mesh sieves;
(2.3) the common fig leaf juice powder 50g of appropriate drying is weighed, rustless steel is put into and is extracted in kettle, with subcritical water be
Extracting solution carries out Subcritical water chromotagraphy to the powder, and extraction time is 20min;Rustless steel extract kettle in subcritical water pressure be
5MPa, temperature are 130 DEG C, and flow velocity is 8L/h;Obtain fig leaf extract;
(2.4) fig leaf extract is obtained into the extract containing psoralen in 55 DEG C of vacuum distillation concentrate dryings,
And in placing it in freeze dryer, lyophilizing is obtained fig leaf extract lyophilized powder, stores for future use.
3. the preparation of clinopodium grass saponin:
(3.1) weigh clinopodium grass coarse powder 100g to be placed in ground conical flask with stopper, add 80% ethanol of mass percentage concentration
Aqueous solution 1000mL, ultrasound carry 30min, filter to get filtrate, and filtering residue is added with 80% ethanol water of 1000mL mass percentage concentration,
Repeat supersound extraction 30min, filter, merge filtrate twice, obtain filtrate;
(3.2) filtrate is concentrated under reduced pressure to give into clinopodium grass saponin extract at 30 DEG C, and is frozen in placing it in freeze dryer
It is drying to obtain clinopodium grass saponin lyophilized powder, store for future use.
4. the preparation of Fructus Fici spray:
A. 45g clinopodium grass saponin lyophilized powders and 15g Irish moss (chondrux) sodium are taken, mix homogeneously is absorbed accelerator
60g。
B. take fig leaf extract lyophilized powder 4g to be mixed and stirred in 250mL beakers uniformly with appropriate amount of deionized water,
Which is uniformly mixed to prepare into mixed solution A with 60g absorption enhancers again.
C. 80g fig fruit extract freeze-drying powder mix homogeneously is added in mixed solution A, obtain mixed solution B.
D. add deionized water in mixed solution B and be settled to 1000mL, Fructus Fici mouth is obtained Jing after biofilter is filtered
Chamber spray, obtained spray is filled in aerosol apparatus, that is, Fructus Fici oral spray product is obtained.
Embodiment 3
The preparation method of Fructus Fici oral spray, comprises the following steps:
1. the preparation of fig fruit extract freeze-drying powder:
(1.1) high-quality fresh fig fruit is selected, after rinsing well, lyophilizing in freeze dryer is put into;
(1.2) fig fruit after lyophilizing is shredded, is put into pulverizer and is ground into powder, cross 60 mesh sieves;
(1.3) dry fig fruit powder 180g is weighed, rustless steel is put into and is extracted in kettle, with subcritical water as extracting
Liquid carries out Subcritical water chromotagraphy to the powder, and extraction time is 25min;Rustless steel extract kettle in subcritical water pressure be
6MPa, temperature are 150 DEG C, and flow velocity is 8L/h;Obtain extract;
(1.4) said extracted thing is obtained containing fig polysaccharide, flavone and fiber in 55 DEG C of vacuum distillation concentrate dryings
The multicomponent activity extract of element etc., and lyophilizing is obtained fig fruit extract freeze-drying powder in placing it in freeze dryer.
Clinopodium grass saponin lyophilized powder is with fig leaf extract lyophilized powder with embodiment 2.
2. the preparation of Fructus Fici spray:
A. 54g clinopodium grass saponin lyophilized powders and 18g Irish moss (chondrux) sodium are taken, mix homogeneously is absorbed accelerator
72g。
B. take fig leaf extract lyophilized powder 2g to be mixed and stirred in 250mL beakers uniformly with appropriate amount of deionized water,
Which is uniformly mixed to prepare into mixed solution A with 72g absorption enhancers again.
C. 120g fig fruit extract freeze-drying powder mix homogeneously is added in mixed solution A, obtain mixed solution B.
D. add deionized water in mixed solution B and be settled to 1000mL, Fructus Fici mouth is obtained Jing after biofilter is filtered
Chamber spray, obtained spray is filled in aerosol apparatus, that is, Fructus Fici oral spray product is obtained.
Embodiment 4
The preparation method of Fructus Fici oral spray, comprises the following steps:
1. the preparation of fig fruit extract freeze-drying powder:
(1.1) high-quality fresh fig fruit is selected, after rinsing well, lyophilizing in freeze dryer is put into;
(1.2) fig fruit after lyophilizing is shredded, is put into pulverizer and is ground into powder, cross 60 mesh sieves;
(1.3) dry fig fruit powder 200g is weighed, rustless steel is put into and is extracted in kettle, with subcritical water as extracting
Liquid carries out Subcritical water chromotagraphy to the powder, and extraction time is 30min;Rustless steel extract kettle in subcritical water pressure be
6MPa, temperature are 160 DEG C, and flow velocity is 8L/h;Obtain extract;
(1.4) said extracted thing is obtained containing fig polysaccharide, flavone and fiber in 55 DEG C of vacuum distillation concentrate dryings
The multicomponent activity extract of element etc., and lyophilizing is obtained fig fruit extract freeze-drying powder in placing it in freeze dryer.
Clinopodium grass saponin lyophilized powder is with fig leaf extract lyophilized powder with embodiment 2.
2. the preparation of Fructus Fici spray:
A. 30g clinopodium grass saponin lyophilized powders and 10g Irish moss (chondrux) sodium are taken, mix homogeneously is absorbed accelerator
40g。
B. take fig leaf extract lyophilized powder 5g to be mixed and stirred in 250mL beakers uniformly with appropriate amount of deionized water,
Which is uniformly mixed to prepare into mixed solution A with 40g absorption enhancers again.
C. 150g fig fruit extract freeze-drying powder mix homogeneously is added in mixed solution A, obtain mixed solution B.
D. add deionized water in mixed solution B and be settled to 1000mL, Fructus Fici mouth is obtained Jing after biofilter is filtered
Chamber spray, obtained spray is filled in aerosol apparatus, that is, Fructus Fici oral spray product is obtained.
Embodiment 5
The preparation method of Fructus Fici oral spray, comprises the following steps:
1. the preparation of fig fruit extract freeze-drying powder:
(1.1) high-quality fresh fig fruit is selected, after rinsing well, lyophilizing in freeze dryer is put into;
(1.2) fig fruit after lyophilizing is shredded, is put into pulverizer and is ground into powder, cross 60 mesh sieves;
(1.3) dry fig fruit powder 100g is weighed, rustless steel is put into and is extracted in kettle, with subcritical water as extracting
Liquid carries out Subcritical water chromotagraphy to the powder, and extraction time is 40min;Rustless steel extract kettle in subcritical water pressure be
7MPa, temperature are 180 DEG C, and flow velocity is 10L/h;Obtain extract;
(1.4) said extracted thing is obtained containing fig polysaccharide, flavone and fiber in 55 DEG C of vacuum distillation concentrate dryings
The multicomponent activity extract of element etc., and lyophilizing is obtained fig fruit extract freeze-drying powder in placing it in freeze dryer.
Clinopodium grass saponin is with fig leaf extract lyophilized powder with embodiment 1.
2. the preparation of Fructus Fici spray:
A. 60g clinopodium grass saponin and 20g Irish moss (chondrux) sodium are taken, mix homogeneously is absorbed accelerator 80g.
B. take fig leaf extract lyophilized powder 2g to be mixed and stirred in 250mL beakers uniformly with appropriate amount of deionized water,
Which is uniformly mixed to prepare into mixed solution A with 80g absorption enhancers again.
C. 50g fig fruit extract freeze-drying powder mix homogeneously is added in mixed solution A, obtain mixed solution B.
D. add deionized water in mixed solution B and be settled to 1000mL, Fructus Fici mouth is obtained Jing after biofilter is filtered
Chamber spray, obtained spray is filled in aerosol apparatus, that is, Fructus Fici oral spray product is obtained.
Comparative example 1 (using high concentration cholate as single absorption enhancer)
Fig fruit extract freeze-drying powder is with fig leaf extract lyophilized powder with embodiment 1.
The preparation of Fructus Fici spray:
By 6g fig leaf extract lyophilized powders, 70g fig fruits extract freeze-drying powder and 60g absorption enhancer cattle sulphurs
Chenodeoxy cholic acid sodium, uses appropriate amount of deionized water mix homogeneously, addition deionized water to be settled to 1000mL, and Jing biofilters are filtered
After must contrast and use Fructus Fici oral spray.
Comparative example 2 (using clinopodium grass saponin as single absorption enhancer)
Fig fruit extract freeze-drying powder, clinopodium grass saponin lyophilized powder and the same embodiment of fig leaf extract lyophilized powder
1。
The preparation of Fructus Fici spray:
By 6g fig leaf extract lyophilized powders, 70g fig fruits extract freeze-drying powder and 60g absorption enhancer wind wheels
Careless saponin lyophilized powder appropriate amount of deionized water mix homogeneously, addition deionized water are settled to 1000mL, and Jing biofilters are filtered
After must contrast and use Fructus Fici oral spray.
Testing example 1
This testing example determines the safety of the Fructus Fici oral spray of the present invention.
The Fructus Fici oral spray of embodiment 1-5 is carried out into gavage experiment to mice (C57 mices, 18-22g), daily
0.5mL, continuous 30 days, has no that mice Novel presentation, absolute organ coefficient and relative organ coefficient are showed no significant change.
Testing example 2
This testing example determines the anti-microbial property of the Fructus Fici oral spray of the present invention.
By staphylococcus aureuses, (purchased from ATCC, 29213) in LB culture medium, (tryptone 10g/L, yeast are extracted article No.
Thing 5g/L, Sodium Chloride 10g/L) in cultivate to logarithmic (log) phase, adjust cell concentration to 10 with LB culture medium6Individual/L, used as containing gold
The bacterium solution of Staphylococcus aureus.
Fructus Fici oral spray, the Fructus Fici mouth of comparative example 1-2 of embodiment 1-5 is separately added in the bacterium solution of 10m
The each 0.5mL of chamber spray, at 37 DEG C cultivate 6 hours, obtain it is antibacterial after sample.
It is according to method specified in GB4789.10-2010 (inspection of food microbiological examination staphylococcus aureuses), right
It is above-mentioned it is antibacterial after sample carry out colony counting method viable bacteria body number detection, as a result as shown in table 1.
Table 1
Visible according to the data of table 1, the Fructus Fici oral spray of the present invention has effective fungistatic effect and antibacterial effect
Fruit significantly, also, contains Fructus Fici extract lyophilized powder, the 2g/L- of 80g/L-150g/L in preferred Fructus Fici oral spray
The fungistatic effect that the preservative of 5g/L, the absorption enhancer of 40g/L-72g/L have becomes apparent from.
Testing example 3
The present embodiment determines the effect of the treatment oral cavity and throat inflammation of the Fructus Fici oral spray of the present invention.
Cavia porcelluss are anesthetized with ether, a cotton pellet is placed in into glass tubing one end (being allowed to concordant with the mouth of pipe) of a diameter of 5mm, then
The phenol solution of 90% volume is dipped in in glass pipe close cotton balls one end, calcination Cavia porcelluss left surface cheek 60s is observed after 24h, Cavia porcelluss oral cavity
Occur the pharyngolaryngitis of diameter 5mm on mucosa, that is, obtain oral cavity and throat inflammation animal model.
The Fructus Fici oral spray of embodiment 1-5, the Fructus Fici oral cavity of comparative example 1-2 are dipped respectively with Disinfectant absorbent cotton to spray
The each 0.3mL of mist agent, is placed on 5min at Cavia porcelluss oral cavity and throat inflammation, and the daily morning and evening is each once.
At the 3rd, 5,7 days respectively with digital picture head record Cavia porcelluss oral cavity and throat inflammation situation, for observing mice pharyngolaryngitis
Healing situation.The 2h after last 1 medication of each cycle, is evaluated after Cavia porcelluss oral cavity and throat inflammation degree by judgment criteria, puts to death globefish
Mus, remove oral cavity and throat local, 100g/L formalin fixes, paraffin embedding, section, microscopy, the pharynx of observation each group Cavia porcelluss oral cavity
Larynx tissue morphology situation.
Pharyngolaryngitis degree judgment criteria:" O ", without pharyngolaryngitis, oral mucosa is normal;" I " has pharyngolaryngitis, and throat surface is without bright
Aobvious redness phenomenon;" II " has pharyngolaryngitis, and there are very thin secretions on throat surface, around without substantially red and swollen;" III " has pharyngolaryngitis, pharynx
Larynx surface secretions are more, and surrounding is with mild inflammatory swelling;" IV " has pharyngolaryngitis, and throat surface secretions are more, surrounding
With obvious inflammatory hyperemia swelling phenomenon.
Symptoms of the guinea pig model oral cavity and throat in different cycles are as shown in table 2.
Table 2
Visible according to the data of table 2, the Fructus Fici oral spray of the present invention has good treatment oral cavity and throat inflammation
Effect and effect is significant, also, contain the Fructus Fici extract lyophilizing of 80g/L-150g/L in preferred Fructus Fici oral spray
In the case of powder, the preservative of 2g/L-5g/L, the absorption enhancer of 40g/L-72g/L, with more significantly therapeutic effect.
With in comparative example 1 using high concentration cholate as single absorption enhancer Fructus Fici oral spray, contrast
Fructus Fici oral spray in example 2 using clinopodium grass saponin as single absorption enhancer is compared, and the present invention is using by wind wheel
The Fructus Fici oral spray oral bacteriostasis of the compounding absorption enhancer of careless saponin and cholate composition, anti-inflammation detumescence effect are more
Significantly, can nourishing the lung to arrest cough, clearing away heat and moistening the bowels, removing toxic substances and promoting subsidence of swelling, with higher popularization productive value.
The preferred embodiment of the present invention described in detail above, but, the present invention is not limited in above-mentioned embodiment
Detail, the present invention range of the technology design in, various simple variants can be carried out to technical scheme.
In inventive formulation, the change of parameter has no effect on the essential effect of product.The change of parameter in preparation method of the present invention
Change has no effect on the preparation of product and nor affects on the essential effect of product, thus in preparation method of the present invention arbitrary parameter combination
The preparation of product is capable of achieving.Will not be described here.
Claims (9)
1. a kind of Fructus Fici oral spray, it is characterised in that in terms of 1000mL, composed of the following components:
Fig fruit extract freeze-drying powder 50g-150g;
Preservative 2g-6g;
Absorption enhancer 40g-80g;
Balance of deionized water;
Described absorption enhancer is made up of clinopodium grass saponin and cholate.
2. Fructus Fici oral spray according to claim 1, it is characterised in that in terms of 1000mL, by following components group
Into:
Fig fruit extract freeze-drying powder 80g-150g;
Preservative 2g-5g;
Absorption enhancer 40g-72g;
Balance of deionized water.
3. Fructus Fici oral spray according to claim 1, it is characterised in that clinopodium grass in described absorption enhancer
Saponin is 3 with the mass ratio of cholate:1.
4. the Fructus Fici oral spray according to claim 1 or 3, it is characterised in that the system of described clinopodium grass saponin
Preparation Method, comprises the following steps:
Clinopodium grass is put into into supersound extraction 30min in the ethanol water of mass percentage concentration 80%, first-time filtrate is filtrated to get,
Filtering residue supersound extraction 30min in the ethanol water of mass percentage concentration 80%, is filtrated to get secondary filtrate, and merging is once filtered
Liquid and secondary filtrate obtain filtrate, and concentrating filter liquor, lyophilizing obtain clinopodium grass saponin extract.
5. Fructus Fici oral spray according to claim 1 and 2, it is characterised in that described preservative is Fructus Fici
Leaf extract.
6. Fructus Fici oral spray according to claim 5, it is characterised in that the system of described fig leaf extract
Preparation Method, comprises the following steps:
Common fig leaf juice obtains common fig leaf juice powder Jing after clean, lyophilizing and crushing;By common fig leaf juice powder with subcritical water as carrying
Taking liquid carries out Subcritical water chromotagraphy, and extraction time is 20min;Subcritical water pressure is 5MPa, and temperature is 130 DEG C, and flow velocity is 8L/
h;The concentrated drying of extract that obtains, lyophilizing, obtain fig leaf extract.
7. Fructus Fici oral spray according to claim 1 and 2, it is characterised in that described fig fruit is extracted
The preparation method of thing lyophilized powder, comprises the following steps:
Fig fruit obtains fig fruit powder Jing after clean, lyophilizing and crushing;By fig fruit powder with subcritical
Water carries out Subcritical water chromotagraphy for extracting solution, and extraction time is 10min-40min;Subcritical water pressure be 4MPa-7MPa, temperature
For 120 DEG C -180 DEG C, flow velocity is 5L/h-10L/h;The concentrated drying of extract that obtains, lyophilizing, obtain fig fruit extraction
Thing lyophilized powder.
8. Fructus Fici oral spray according to claim 1, it is characterised in that described described cholate is from sweet
One kind or two in ammonia sodium cholate, glycochenodeoxycholate sodium, sodium taurocholate, Irish moss (chondrux) sodium, NaTDC
More than kind.
9. the preparation method of the Fructus Fici oral spray according to any one of claim 1-8, it is characterised in that include with
Lower step:
(1) clinopodium grass saponin is mixed homogeneously into the accelerator that is absorbed with cholate;
(2) by absorption enhancer, preservative and appropriate amount of deionized water mix homogeneously, mixed solution A is obtained;
(3) in mixed solution A fig fruit extract freeze-drying powder, mix homogeneously is added to obtain mixed solution B;
(4) add deionized water in mixed solution B and be settled to 1000mL, obtain Fructus Fici oral spray Jing after filtering antibacterial.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611077374.9A CN106511471B (en) | 2016-11-30 | 2016-11-30 | A kind of fig oral spray and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611077374.9A CN106511471B (en) | 2016-11-30 | 2016-11-30 | A kind of fig oral spray and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106511471A true CN106511471A (en) | 2017-03-22 |
CN106511471B CN106511471B (en) | 2019-11-22 |
Family
ID=58354008
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611077374.9A Active CN106511471B (en) | 2016-11-30 | 2016-11-30 | A kind of fig oral spray and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106511471B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108813465A (en) * | 2018-07-03 | 2018-11-16 | 浙江省林业科学研究院 | A kind of fig function chewable tablets and preparation method thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1593480A (en) * | 2004-07-02 | 2005-03-16 | 陈小保 | Fig buccal tablet and its preparing process |
CN101623304A (en) * | 2009-01-22 | 2010-01-13 | 九芝堂股份有限公司 | Pharmaceutical composition for nasal administration |
CN101797289A (en) * | 2010-04-07 | 2010-08-11 | 西北大学 | Oral spraying agent prepared from traditional Chinese medicine and preparation method thereof |
CN105770658A (en) * | 2016-05-17 | 2016-07-20 | 上饶市莎江高科生物有限公司 | Traditional Chinese medicine preparation for treating oral disease |
CN105998542A (en) * | 2016-05-26 | 2016-10-12 | 孙明香 | Traditional Chinese medicine spray for treating acute laryngopharyngitis and preparation method of traditional Chinese medicine spray |
-
2016
- 2016-11-30 CN CN201611077374.9A patent/CN106511471B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1593480A (en) * | 2004-07-02 | 2005-03-16 | 陈小保 | Fig buccal tablet and its preparing process |
CN101623304A (en) * | 2009-01-22 | 2010-01-13 | 九芝堂股份有限公司 | Pharmaceutical composition for nasal administration |
CN101797289A (en) * | 2010-04-07 | 2010-08-11 | 西北大学 | Oral spraying agent prepared from traditional Chinese medicine and preparation method thereof |
CN105770658A (en) * | 2016-05-17 | 2016-07-20 | 上饶市莎江高科生物有限公司 | Traditional Chinese medicine preparation for treating oral disease |
CN105998542A (en) * | 2016-05-26 | 2016-10-12 | 孙明香 | Traditional Chinese medicine spray for treating acute laryngopharyngitis and preparation method of traditional Chinese medicine spray |
Non-Patent Citations (1)
Title |
---|
《生物药物制剂学》: "《生物药物制剂学》", 30 June 2011, 杭州:浙江大学出版社 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108813465A (en) * | 2018-07-03 | 2018-11-16 | 浙江省林业科学研究院 | A kind of fig function chewable tablets and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN106511471B (en) | 2019-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105410346A (en) | Cultured penaeus vannamei survival rate improving traditional Chinese medicine preparation and preparation method thereof | |
CN106107375A (en) | Folium Bambosae flavone extracts and prepares this Folium Bambosae flavone health promoting beverage and the method for beverage | |
KR20110128385A (en) | The herb medicine composition material and the manufacturing process for pimple skin-improvement uses by midam cheonggyeolan | |
CN108813501B (en) | Health-preserving honey paste with functions of clearing heat, moistening lung, relieving cough, reducing phlegm, relieving asthma and regulating human body functions | |
CN113730479A (en) | Composition with health care function and preparation method and application thereof | |
CN107635573A (en) | Atopic dermatitis Chinese medicine preparation, preparation method and its usage | |
CN102485237A (en) | Sweet wormwood herb brewed liquid, brewing technology thereof, and preparation method of starter thereof | |
CN108813465A (en) | A kind of fig function chewable tablets and preparation method thereof | |
CN104398426A (en) | Mask for treating common acne | |
CN106171334A (en) | A kind of cuttage breeding method of Guangxi Wild sweet tea | |
CN101972025A (en) | Bamboo vinegar health care beverage and preparation method thereof | |
CN106511471B (en) | A kind of fig oral spray and preparation method thereof | |
CN104383068B (en) | A kind of highly efficient anti-virus, antibacterial herbal medicine | |
CN110558108A (en) | Chinese herbal medicine planting and cultivating system and device with effects of preventing and treating hyperlipidemia | |
CN106490609A (en) | A kind of Isodon amethystoides (Benth.) C.Y.Wuet Hsuen buccal tablet and its production method | |
CN107375982B (en) | Air freshener suitable for northern houses | |
KR20180000874A (en) | Nutritional food composition helping detoxification or elimiation of fine dust, heavy metals and antibiotics, and its manufacturing method | |
CN108670912A (en) | A kind of preparation method of pure natural spice Essence | |
CN107041445A (en) | A kind of bamboo juice leaf of bamboo health protection tea for preventing and treating hypertension, hyperglycemia | |
CN113599429A (en) | Electronic atomized liquid for oral care | |
Li | The health efficacy of aloe and its development and utilization | |
KR20030079289A (en) | The carbonated soft drinks a manufacturing process and a composition of ling indigestion hangover cures. | |
CN105477625B (en) | A kind of absorption dust discharge Chinese herbal and crude drugs preparationses and preparation method thereof | |
CN114568557B (en) | Ginseng polysaccharide sweet golden flower black tea and preparation method thereof | |
CN113615793B (en) | Fresh-keeping method capable of keeping effective components of gastrodia elata, fresh-keeping agent and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |